BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 25961452)

  • 1. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.
    Burkett PR; Meyer zu Horste G; Kuchroo VK
    J Clin Invest; 2015 Jun; 125(6):2211-9. PubMed ID: 25961452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
    Astry B; Venkatesha SH; Moudgil KD
    Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenicity of Th17 cells in autoimmune diseases.
    Yasuda K; Takeuchi Y; Hirota K
    Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected targets and triggers of autoimmunity.
    Lee Y; Collins M; Kuchroo VK
    J Clin Immunol; 2014 Jul; 34 Suppl 1(0 1):S56-60. PubMed ID: 24789684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
    Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
    Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells.
    Kastirr I; Maglie S; Paroni M; Alfen JS; Nizzoli G; Sugliano E; Crosti MC; Moro M; Steckel B; Steinfelder S; Stölzel K; Romagnani C; Botti F; Caprioli F; Pagani M; Abrignani S; Geginat J
    J Immunol; 2014 Oct; 193(7):3322-31. PubMed ID: 25172491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
    J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting IL-17 in autoimmunity and inflammation.
    Kim BS; Park YJ; Chung Y
    Arch Pharm Res; 2016 Nov; 39(11):1537-1547. PubMed ID: 27576555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-23: one cytokine in control of autoimmunity.
    Croxford AL; Mair F; Becher B
    Eur J Immunol; 2012 Sep; 42(9):2263-73. PubMed ID: 22949325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Th17 cell differentiation by intestinal commensal bacteria.
    Atarashi K; Tanoue T; Umesaki Y; Honda K
    Benef Microbes; 2010 Nov; 1(4):327-34. PubMed ID: 21831771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
    Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
    Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
    Du R; Zhao H; Yan F; Li H
    J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-23/IL-17 immune axis in Guillain Barré Syndrome: Exploring newer vistas for understanding pathobiology and therapeutic implications.
    Debnath M; Nagappa M; Murari G; Taly AB
    Cytokine; 2018 Mar; 103():77-82. PubMed ID: 29331587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-17 and IL-22 in autoimmunity and cancer.
    Blake SJ; Teng MW
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key molecules in the differentiation and commitment program of T helper 17 (Th17) cells up-to-date.
    Hemdan NY; Birkenmeier G; Wichmann G
    Immunol Lett; 2012 Dec; 148(2):97-109. PubMed ID: 23036716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals.
    Chewning JH; Weaver CT
    J Immunol; 2014 Nov; 193(10):4769-77. PubMed ID: 25381358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation.
    Wang J; Li F; Wei H; Lian ZX; Sun R; Tian Z
    J Exp Med; 2014 Nov; 211(12):2397-410. PubMed ID: 25366965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.